SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000792977-20-000058
Filing Date
2020-06-04
Accepted
2020-06-04 16:49:12
Documents
2
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159130373490595.html 4  
1 FORM 4 wf-form4_159130373490595.xml 4 6251
2 POA - 2020 amag-section16poa2020paulf.txt EX-24 3117
  Complete submission text file 0000792977-20-000058.txt   10918
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Issuer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O RESTORBIO, INC. 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address
FONTEYNE PAUL R. (Reporting) CIK: 0001727550 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10865 | Film No.: 20943490